Home

Course of disease

Read time: 4 min

Early intervention and re-assessment are essential to optimize outcomes for patients with major depressive disorder

Early intervention and treatment adjustment as necessary to provide complete symptomatic relief and...

Read time: 3 min

Satellite symposium

Tackling the pervasive impact of migraine

In a satellite symposium at the 16th European Headache Congress, December 7–10, 2022,...

Read time: 2 min

Congress highlights

“Schizophrenia: One disease or hundreds of diseases?”

Schizophrenia is a heterogeneous disease. The symptoms, course and outcome vary widely among...

Alzheimer's Disease

Read time: 3 min

Congress highlights

New perspectives on Alzheimer’s disease

Alzheimer’s disease is not part of normal aging. It is a brain disorder and not all people...

Depression, Schizophrenia

Read time: 3 min

Satellite symposium

Act early to improve outcomes in schizophrenia and major depressive disorder

At the 35th ECNP Congress in Vienna, Austria (15th−18th Oct), in a symposium...

Read time: 3 min

Satellite symposium

Patient-centric management of medication-overuse headache

Medication overuse is common among patients who are impacted by migraine and up to 70% of patients...

Read time: 3 min

Congress highlights

Debate continues over long-term antipsychotic use

Care in choice of agent, caution in efforts to discontinue therapy and the need for more studies...

Read time: 2 min

Congress highlights

Are prior mood disorders more important than positive symptoms for predicting psychosis?

Predicting which individuals will develop a psychotic disorder or transition from high risk of...

Neurotoriun

Neurotorium is your new point of reference for educational content on psychiatry, neurology, and neuroscience.

Country selection

We are registering that you are located in Brazil - if that's correct then please continue to Progress in Mind Brazil

Not located in Brazil?
Go to a different regional HUB

Continue to Progress in Mind Continue to Progress in Mind Brazil Continue to Progress in Mind MENA Continue to Progress in Mind Spain Continue to Progress in Mind Italy Continue to Progress in Mind Greece Continue to Progress in Mind South East Asia Continue to Progress in Mind Middle East & Africa Continue to Progress in Mind United Kingdom Continue to Progress in Mind Sweden Continue to Progress in Mind Norge Continue to Progress in Mind Denmark Continue to Progress in Mind Japan RC Continue to Progress in Mind България Continue to Progress in Mind Israel Continue to Progress in Mind Sweden Continue to Progress in Mind Finland Continue to Progress in Mind Ukraine Continue to Progress in Mind Belgium & Luxembourg Continue to Progress in Mind Switzerland Continue to Progress in Mind Germany Continue to Progress in Mind Austria

You are leaving Progress in Mind

Continue to

Cancel

Progress in Mind Belux

Accept Cancel

Login as a registered health care professional

Please enter your email to continue

Register as a health care professional

Please enter your email to continue

Hello
Please confirm your email

We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.

The information on this site is exclusively intended for health care professionals.

All the information included in the Website is related to diseases, investigations and existing or potential treatment options and, therefore, directed to health professionals . The technical information of the drugs is provided merely informative, being the responsibility of the professionals authorized to prescribe drugs and decide, in each concrete case, the most appropriate treatment to the needs of the patient.

Accept

Decline

Congress

Register for access to Progress in Mind in your country